General Practice Doctors in Virgin Island Medicare Details, Address, Contact
4 General Practice doctors found. Showing 1 - 4
 Dr. Vilma Colon, M.D. General Practice Medicare: Not Enrolled in Medicare Practice Location: Rr 2 Box 10553, The Village Mall Bay 14-16, Kingshill, VI 00850 Phone: 340-778-5553 Fax: 340-778-9497 |
 Seshagiri R Alla, MD JD General Practice Medicare: Medicare Enrolled Practice Location: 1606 6th, Street Sugar Estate, St Thomas, VI 00802 Phone: 340-777-8210 Fax: 340-776-9739 |
Srinivasa Lakshmi Alla, MD General Practice Medicare: Medicare Enrolled Practice Location: 1603 Sixth St, Sugar Estate, St Thomas, VI 00802 Phone: 340-777-8210 Fax: 340-776-9739 |
Dr. Garfield Alexander Less, M.D. General Practice Medicare: May Accept Medicare Assignments Practice Location: 1601 6th St. 1-3 Sugar Est., St. Thomas, VI 00802 Phone: 340-776-9786 Fax: 340-774-3211 |
News Archive
Quarterly UK Clostridium difficile and MRSA figures
Latest figures from the Health Protection Agency show there were 55,681 cases of Clostridium difficile infection reported in patients aged 65 years and above in England in 2006.
Merck, PDS Biotechnology enter licensing agreement for Versamune
PDS Biotechnology Corporation announced today that they have entered into an exclusive worldwide licensing agreement with Merck KGaA, Darmstadt, Germany, for use of PDS Biotechnology's novel Versamune nanotechnology platform in two of Merck's investigational antigen-specific cancer immunotherapies currently in pre-clinical development.
E-QURE inks distribution agreement with Rubifarm S.A.
E-QURE Corp. (OTCQB: EQUR), a Delaware Corporate engaged in the commercialization of its Bio-electrical Signal Therapy device ("BST Device"), a new and novel electrotherapy for the noninvasive treatment of hard to heal chronic wounds, today announced that the Company has signed its first distribution agreement with Rubifarm S.A., an Argentinian distributor specializing in medical devices, and. The agreement goes into effect immediately.
Research findings offer prime drug targets to treat rare liver cancer that strikes young people
After years of rigorous research, a team of scientists has identified the genetic engine that drives a rare form of liver cancer. The findings offer prime targets for drugs to treat the usually lethal disease, fibrolamellar hepatocellular carcinoma (FL-HCC), which mainly strikes adolescents and young adults.
› Verified 3 days ago